Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Purple Biotech Ltd. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +1 vs. Q4 2021
- Shares held
- 449.3K
- −602.0K (−57.3%) vs. Q4 2021
- Total value
- $1.77M
- −$2.32M (−56.8%) vs. Q4 2021
- New holders
- 4
- 1 more added
- Sold out
- 3
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 271,394 | $1.07M | 0.00% | −7,900−2.8% | Reduced |
| Renaissance Technologies LLC | 50,280 | $198.0K | 0.00% | +50,280 | New |
| Sabby Management, LLC | 26,672 | $105.0K | 0.05% | +26,672 | New |
| Group One Trading, L.P. | 26,037 | $103.0K | 0.00% | +17,957+222.2% | Added |
| Susquehanna International Group, LLP | 24,497 | $97.0K | 0.00% | −9,828−28.6% | Reduced |
| Washington Trust Bank | 16,454 | $65.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,666 | $50.0K | 0.00% | 00.0% | Unchanged |
| Venture Visionary Partners LLC | 11,068 | $43.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7,833 | $31.0K | 0.00% | −15,593−66.6% | Reduced |
| UBS Group AG | 2,002 | $8.00K | 0.00% | −1,066−34.7% | Reduced |
| North Star Investment Management Corp. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 108 | $0 | 0.00% | +108 | New |
| IFP Advisors, Inc | 10 | – | – | +10 | New |
| ARK Investment Management LLCSuperinvestorARK Invest | 0 | $0 | 0.00% | −662,499−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Cornerstone Advisory, LLC | 0 | $0 | 0.00% | −53−100.0% | Sold out |